MedTrace Logo

Fish Oil vs. Placebo on Subjective Effects of Alcohol

NCT03010917 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2022-09-22

No results posted yet for this study

Summary

This project represents a first step in examining the potential use of fish oil for the treatment of alcohol use disorder (AUD). The investigators will be testing for attenuation of alcohol-induced sedative and stimulant effects, as well as cognitive effects and cerebellar effects in healthy social drinkers.

Conditions

  • Alcohol Dependence

Interventions

DRUG

Fish Oil with ethanol and placebo ethanol infusions

Fish Oil with ethanol and placebo ethanol infusions

DRUG

Placebo with ethanol and placebo ethanol infusions

Placebo with ethanol and placebo ethanol infusions

Sponsors & Collaborators

  • VA Connecticut Healthcare System

    collaborator FED

  • Yale University

    lead OTHER

Principal Investigators

  • Ismene Petrakis, M.D. · Yale University/VA Connecticut Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-02
Primary Completion
2021-05-30
Completion
2021-09-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03010917 on ClinicalTrials.gov